Cover art for Eli Lilly’s Weight-Loss Boom Is Rewriting Big Pharma
Elon Musk Podcast

Eli Lilly’s Weight-Loss Boom Is Rewriting Big Pharma

1mo ago13m
Eli Lilly raised its full-year outlook after strong demand for its diabetes and obesity treatments drove a major jump in revenue and profit.

In this episode, we look at how GLP-1 drugs have become one of the most important growth engines in health care—and why the competition to own this market is only getting fiercer.

The bigger story is what happens when one product category grows so fast that it reshapes an entire company’s strategy, valuation, and future.

Support the Show

• Amazon picks: https://amzn.to/4fUGHEm
• Amazon picks: https://amzn.to/4pUHt8Q
• Amazon picks: https://amzn.to/45a4MC9
• Need a website or app? https://hireawebteam.com
• Support us on Patreon: https://www.patreon.com/c/StageZeroNews?view_as=patron&vanity=StageZeroNews
• Subscribe on Supercast: https://clubelon.supercast.com/

Disclosure: Amazon links may earn a commission from qualifying purchases.
Loading content...

Read the full transcript

Matterfact has every podcast on Apple Podcasts and Spotify: 700K+ channels, 120M+ episodes.

Already have access? Sign in

Want podcast transcripts in Claude? Subscribe, then follow this guide.Read the guide

The candid version is on a podcast, not the earnings call.

Matterfact turns the conversations your coverage is already having into a searchable, citable record — across every episode, not just this one.